Therefore, CMTM8 acts as an attenuator of EGF-induced signaling by facilitating ligand-induced EGFR endocytosis and subsequent desensitization, indicating that the alteration of CMTM8 levels in cancer might affect EGFR signaling. The gene discussed is CMTM8; the disease is cancer.